Libtayo (cemiplimab) was cleared in 2018 for treating advanced CSCC in patients who are not candidates for curative surgery ...

Researchers are also investigating the PD-1 immune checkpoint inhibitor as treatment before surgical and radiation treatment.

What can I do to help my own odds? The answer, data increasingly shows, is to go back to the basics: exercise and a good diet ...